Regenx Announces Proposed Debenture Offering With a $750,000 Lead Order
EDMONTON, Alberta, Dec. 18, 2023 (GLOBE NEWSWIRE) — Regenx Tech Corp., (the “Corporation” or “Regenx”) (TSXV: RGX) (OTCQB: RGXT) (FSE: […]
Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound
VANCOUVER, British Columbia, Dec. 18, 2023 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) […]
